Childhood Discoid Lupus erythematosus and Antimalarials by Meurer, Michael
Editorial
Dermatology 2003;207:133
DOI: 10.1159/000071781
Childhood Discoid Lupus
erythematosus and Antimalarials
Michael Meurer
Department of Dermatology, Dresden University of Technology, Dresden, Germany
Michael Meurer, MD, Professor and Chairman
Department of Dermatology
Dresden University of Technology, Fetscherstrasse 74
DE–01307 Dresden (Germany)
Tel. +49 351 458 2497, Fax +49 351 458 4338, E-Mail meurer@rcs.urz.tu-dresden.de
ABC
Fax + 41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
© 2003 S. Karger AG, Basel
1018–8665/03/2072–0133$19.50/0
Accessible online at:
www.karger.com/drm
The article by Sonntag et al. [1] in this issue of Derma-
tology describes 3 children with lupus erythematosus (LE)
tumidus, a rare subtype of cutaneous LE which has pre-
viously not been reported in this age group. Discoid LE
(DLE) is very uncommon in childhood: less than 2% of all
patients with DLE have onset of the disease before the age
of 10 years [2]. Unlike in adult DLE, there does not seem
to be a female predominance, but, notably, familial occur-
rence of DLE, systemic LE (SLE), rheumatoid arthritis or
chronic granulomatous disease has been described in
more than 30% of children with DLE. A regular long-term
monitoring seems advisable since up to 25% of affected
children with DLE progressed to SLE, sometimes 10 or
more years later.
The children often present with discoid erythematous
scaly plaques and papules usually on the face and scalp or
in UV-exposed sites, although photosensitivity in chil-
dren is reported only at a low incidence. Further common
clinical signs are telangiectasia, follicular plugging and
pigmentary changes. Generalized disease with lesions
both above and below the neck can been seen in about
40% of the children documented. The histologic, immu-
nofluorescence and serologic features in children with
DLE are similar to those in adults, with positive antinu-
clear antibody findings in about 25%.
Treatment consists primarily of topical corticosteroids
or of antimalarials in patients not responding to topical
therapy. Traditional indications for antimalarial therapy
in children include malaria, juvenile rheumatoid arthritis,
SLE and DLE. The guidelines for safe and effective dosages
of antimalarials in children formulated in the pediatric
rheumatology literature [3, 4] can be applied for DLE in
children as well: they recommend hydroxychloroquine
6 mg/kg lean body weight/day for 1 month followed by
daily oral doses of 5 mg/kg body weight or chloroquine
3.5 mg/kg/day. To facilitate the accurate delivery of the cal-
culated daily dose to a child, the tablets may be pulverized
and the appropriate powdered dose mixed with pectin-con-
taining food and given immediately before or after a meal.
Ocular side effects have not been reported in children
treated with antimalarials; more common in children are
nausea and vomiting caused by gastric irritation. These
side effects are generally dose-related.
Limitations of cumulative doses or length of treatment
have not been determined, but a close follow-up and mon-
itoring including ophthalmologic examination, complete
blood cell counts, liver and kidney function tests every
3–6 months are essential.
There exist reports on fatal poisoning and toxic side
effects due to overdosage in children. But overall, on a
milligram-per-kilogram basis, the safety profile of chloro-
quine and hydroxychloroquine is equivalent in adult and
pediatric patients with DLE.
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